Exhibit 99.3 It Is Unlawful To Consummate A Sale Or Transfer Of This Security, Or Any Interest Therein, Or To Receive Any Consideration Therefor, Without The Prior Written Consent Of The Commissioner Of Corporations Of The State Of California, Except...Incentive Stock Option Agreement • February 14th, 2000 • Tularik Inc • Services-commercial physical & biological research
AGREEMENT ---------Indemnification Agreement • October 15th, 1999 • Tularik Inc • Delaware
TULARIK INC.Common Stock Purchase Agreement • December 7th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
TULARIK INC. and WELLS FARGO BANK MINNESOTA, N.A. as Rights Agent RIGHTS AGREEMENT Dated as of December 11, 2002Rights Agreement • December 13th, 2002 • Tularik Inc • Pharmaceutical preparations • Delaware
THIS RIGHTS AGREEMENT ("Agreement"), dated as of December 11, 2002, between TULARIK INC., a Delaware corporation (the "Company"), and WELLS FARGO BANK MINNESOTA, N.A. ("Rights Agent").
Exhibit 10.6 AMENDMENT NO. 1 TO COLLABORATION AGREEMENT BETWEEN TULARIK INC. AND SUMITOMO PHARMACEUTICALS CO., LTD THIS AMENDMENT NO. 1 (this "Amendment") to the Collaboration Agreement dated as of January 31, 1995 (the "Collaboration Agreement") by...Collaboration Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • California
WitnessethLicense Agreement • August 11th, 2000 • Tularik Inc • Services-commercial physical & biological research • California
EXHIBIT 1.1 FORM OF UNDERWRITING AGREEMENT 6,000,000 Shares TULARIK INC. Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • March 3rd, 2000 • Tularik Inc • Services-commercial physical & biological research • New York
TULARIK INC.Registration Rights Agreement • October 15th, 1999 • Tularik Inc • California
WitnessethOption Agreement • August 11th, 2000 • Tularik Inc • Services-commercial physical & biological research • California
U.S. UNDERWRITING AGREEMENT ---------------------------u.s. Underwriting Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
INTERNATIONAL UNDERWRITING AGREEMENT ------------------------------------International Underwriting Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
EXHIBIT 10.25 AGREEMENT AND GENERAL RELEASE ----------------------------- Tularik Inc., Two Corporate Drive, San Francisco, CA 94080, its affiliates, subsidiaries, divisions, successors and assigns and the employees, officers, directors and agents...General Release Agreement • October 15th, 1999 • Tularik Inc • California
AGREEMENT ---------Rental Agreement • October 15th, 1999 • Tularik Inc
Tularik Inc. 6,000,000 Shares Common Stock ($0.001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2003 • Tularik Inc • Pharmaceutical preparations • New York
Tularik Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”) an aggregate of 6,000,000 shares and, at the election of the Underwriters, up to an additional 900,000 shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The aggregate of 6,000,000 shares to be sold by the Company is herein called the “Firm Shares” and the aggregate of 900,000 additional shares to be sold by the Company is herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 1 hereof are herein collectively called the “Shares.” The Shares are described in the Prospectus which is referred to below.
EXHIBIT 10.17 STOCK PURCHASE AGREEMENT This Agreement is made by and between Tularik Inc., a California corporation (the "Company"), and the 1987 Swanson Family Trust ("Purchaser"). 1. Purchase of Shares. Purchaser agrees to purchase from the Company,...Stock Purchase Agreement • October 15th, 1999 • Tularik Inc
2.2 Early Possession. Tenant shall have the nonexclusive right to occupy ---------------- and take possession of the Phase II Site from and after the date of Landlord's delivery of the Structural Completion Certificate described in clause (i) of...Build-to-Suit Lease • October 15th, 1999 • Tularik Inc • California
Exhibit 10.14 September 20, 1998 Mr. Masakazu Kakei Executive Director and Member of Board Japan Tobacco Inc. JT Building, 2-1 Toranomon, 2-chome Minato- ku, Tokyo 105-8422, Japan Re: Preliminary Research, Development and Marketing Agreement between...Preliminary Research, Development and Marketing Agreement • December 21st, 1999 • Tularik Inc • Services-commercial physical & biological research • California
RECITALSLicensing Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
Exhibit 10.9 Amendment No. 1 TO Research Collaboration and License Agreement Between Tularik Inc. and Syntex (U.S.A.) Inc. This Amendment No. 1 (this "Amendment") to the Research Collaboration and License Agreement dated as of July 8, 1997 (the...Research Collaboration and License Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research
betweenCollaboration Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • California
Exhibit 4.3 TULARIK INC. INVESTOR RIGHTS AGREEMENT October 31, 1997 TABLE OF CONTENTSInvestor Rights Agreement • October 15th, 1999 • Tularik Inc • Delaware
SUBLEASESublease • October 15th, 1999 • Tularik Inc
Exhibit 10.10 RESEARCH AGREEMENT Research Agreement between Cold Spring Harbor Laboratory, hereinafter referred to as "CSHL," and Tularik Inc., hereinafter referred to as "Sponsor". This Agreement is entered into as of October 3, 1997 and will be...Research Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
Exhibit 10.8 AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • California
Exhibit 10.7 AMENDMENT NO. 2 TO RESEARCH, COLLABORATION AND LICENSE/DEVELOPMENT AGREEMENT BETWEEN TULARIK INC. AND TAISHO PHARMACEUTICAL CO., LTD. THIS AMENDMENT NO. 2 (this "Amendment") to the Research, Collaboration and License/Development Agreement...Research, Collaboration and License/Development Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • Tokyo
AGREEMENT AND PLAN OF MERGER BY AND AMONG AMGEN INC., ARROW ACQUISITION, LLC AND TULARIK INC. DATED AS OF MARCH 28, 2004Merger Agreement • March 30th, 2004 • Tularik Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER, dated as of March 28, 2004 (this “Agreement”), by and among AMGEN INC., a Delaware corporation (“Parent”), ARROW ACQUISITION, LLC, a Delaware limited liability company wholly-owned by Parent (“Merger Sub”), and TULARIK INC., a Delaware corporation (the “Company”).
EXHIBIT 10.19 SUBLEASESublease • October 15th, 1999 • Tularik Inc
RecitalsScreening Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
STOCKHOLDER VOTING AGREEMENT BY AND BETWEEN AMGEN INC. and The Stockholders Identified on Schedule A attached hereto Dated as of March 28, 2004Stockholder Voting Agreement • March 30th, 2004 • Tularik Inc • Pharmaceutical preparations • Delaware
This STOCKHOLDER VOTING AGREEMENT (this “Agreement”) is entered into as of March 28, 2004, by and among Amgen Inc., a Delaware corporation (“Parent”), and the Stockholders of Tularik Inc., a Delaware corporation (the “Company”) identified on Schedule A attached hereto (each a “Stockholder” and collectively, the “Stockholders”).
CONSULTING AGREEMENTConsulting Agreement • August 14th, 2002 • Tularik Inc • Pharmaceutical preparations • California
THIS AGREEMENT is made by and between Tularik Inc., a Delaware corporation (the “Company”), and Craig A.P.D. Saxton, M.D. (“Consultant”), effective April 18, 2002 for the purpose of setting forth the terms and conditions by which the Company will acquire Consultant’s services on a temporary basis.
AMENDMENT TO RIGHTS AGREEMENT BETWEEN TULARIK INC. AND WELLS FARGO BANK MINNESOTA, N.A.Rights Agreement • November 12th, 2003 • Tularik Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT TO RIGHTS AGREEMENT (the “Amendment”) is made this 10th day of November, 2003, by and between TULARIK INC., a Delaware corporation (the “Company”), and WELLS FARGO BANK MINNESOTA, N.A. (the “Rights Agent”).
AMENDMENT NO. 1 TO LICENSING AGREEMENT BETWEEN TULARIK INC. AND ELI LILLY AND COMPANYLicensing Agreement • August 13th, 2001 • Tularik Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this "Amendment") to the Licensing Agreement dated as of September 30, 1999 (the "Agreement") by and between Eli Lilly And Company, an Indiana corporation, having offices at Lilly Corporate Center, Indianapolis, Indiana 46285 ("Lilly"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of January 10, 2001. Lilly and Tularik may be referred to herein individually as a "Party" or, collectively, as "Parties".
FIRST AMENDMENT TO BUILD-TO-SUIT LEASEBuild-to-Suit Lease • May 7th, 2004 • Tularik Inc • Pharmaceutical preparations • California
THIS FIRST AMENDMENT TO BUILD-TO-SUIT LEASE (“First Amendment”) is entered into as of January 22, 2003 (the “Effective Date”) between SLOUGH BTC, LLC, a Delaware limited liability company (“Landlord”) and TULARIK INC., a Delaware corporation (“Tenant”), with reference to the following facts:
INDUSTRIAL LEASE AGREEMENT GRAND/ROEBLING INVESTMENT COMPANY a California limited partnership LANDLORD and SHAMAN PHARMACEUTICALS, INC. a California corporation TENANT EFFECTIVE DATE OF EXECUTION: January 1, 1993Industrial Lease Agreement • May 14th, 2001 • Tularik Inc • Pharmaceutical preparations • California
Real Property: Parcels 1, 2 and 3, more particularly described in Exhibit "B-1" attached hereto and incorporated herein by reference, known as San Mateo County Assessor Parcel Numbers 015-041-270 and 015-041-200 (together, the "Real Property"). A Plot Plan outlining the Real Property, the location of the three (3) Buildings site on the Real Property, and the Easement and Driveway (referenced below) is attached hereto as Exhibit "A" and incorporated herein by reference.
COLLABORATION AGREEMENTCollaboration Agreement • August 14th, 2002 • Tularik Inc • Pharmaceutical preparations • Tokyo
This Collaboration Agreement (“Agreement”) is entered into as of June 10, 2002 (the “Effective Date”), between Tularik Inc. (“Tularik”), a Delaware corporation, with offices at Two Corporate Drive, South San Francisco, CA 94080 and Sankyo Company, Limited (“Sankyo”), a corporation organized under the laws of Japan with offices at 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan (individually, a “Party” and, collectively, the “Parties”).
